Leers, Jessica M.
Knepper, Laura http://orcid.org/0000-0003-3501-5109
van der Veen, Arjen
Schröder, Wolfgang
Fuchs, Hans
Schiller, Petra
Hellmich, Martin
Zettelmeyer, Ulrike
Brosens, Lodewijk A. A.
Quaas, Alexander
Ruurda, Jelle P.
van Hillegersberg, Richard
Bruns, Christiane J.
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KG1816)
Article History
Received: 13 May 2020
Accepted: 8 July 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: To date, the study protocol has been approved by the ethics committee of the University of Cologne (reference number 19–1376), the University of Leipzig Medical Center (reference number 053/20-lk), University Hospital rechts der Isar (reference number 57/20 S-HK), University Medical Center of the Johannes Gutenberg University Mainz (reference number 2020–14858) and the Medical Center – University of Freiburg (reference number 80/20). The ethics committee of the Charité – Universitätsmedizin Berlin does not require an additional ethics vote, after the study protocol has been approved by other German ethics boards. In case of important protocol modifications, the Principal Coordinating Investigator will inform the Principal Investigators of all trial sites. They will then forward the amendments to the associated ethics committees and trial participants.Written informed consent was and will be obtained from all participants. Investigators, Sub-Investigators and study nurses will be allowed to obtain informed consent.The following twelve centers were selected for participation in the CARDIA trial. Table removed
: Not applicable.
: LAAB is an Associate Editor for BMC Cancer. All other authors declare that they have no competing interests.